Clinical Trial Update: Evaluation to Assess the Long Term Safety of Tacrolimus Ointment for Atopic Dermatitis [Phase 4]

View source ↗

Summary

A Phase 4 long-term safety trial evaluating tacrolimus ointment for atopic dermatitis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Tacrolimus ointment (tacrolimus)

Snippet

Sponsor: University of California, Davis | Conditions: Atopic Dermatitis | Phase 4 | Status: WITHDRAWN